US4021540A
(en)
|
1975-07-28 |
1977-05-03 |
Ortho Diagnostics Inc. |
Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material
|
JPS5341420A
(en)
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
JPS604422B2
(ja)
|
1976-10-07 |
1985-02-04 |
持田製薬株式会社 |
抗原の定量方法
|
US4174388A
(en)
|
1977-02-14 |
1979-11-13 |
Merck & Co., Inc. |
Method for preparing hepatitis B immune globulin
|
US4305870A
(en)
|
1979-01-31 |
1981-12-15 |
Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte |
Intravenous plasma derivatives and their production
|
JPS55124719A
(en)
|
1979-03-22 |
1980-09-26 |
Kowa Co |
Preparation of immune globulin administrable by intravenous injection
|
FR2460139A1
(fr)
|
1979-06-29 |
1981-01-23 |
Pasteur Institut |
Fraction antigenique glycopeptidique vaccinante a tres grande immunogenicite isolee de cultures de germes pathogenes, procedes d'isolement de cette fraction et vaccins contenant ladite fraction
|
FR2475900A1
(fr)
|
1980-02-20 |
1981-08-21 |
Fabre Sa Pierre |
Complexe vaccinal contenant un antigene specifique et vaccin le contenant
|
US4346073A
(en)
|
1980-04-11 |
1982-08-24 |
The United States Of America As Represented By The Department Of Health And Human Services |
Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
|
US4486530A
(en)
|
1980-08-04 |
1984-12-04 |
Hybritech Incorporated |
Immunometric assays using monoclonal antibodies
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
US5360897A
(en)
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
US4482483A
(en)
|
1983-04-06 |
1984-11-13 |
Armour Pharmceutical Company |
Composition of intravenous immune globulin
|
US4587121A
(en)
|
1983-06-14 |
1986-05-06 |
Miles Laboratories, Inc. |
High titer Pseudomonas immune serum globulin
|
US4617379A
(en)
|
1983-06-14 |
1986-10-14 |
Miles Laboratories, Inc. |
High titer cytomegalovirus immune serum globulin
|
CA1247527A
(en)
|
1983-06-14 |
1988-12-28 |
Michael S. Collins |
High titer pseudomonas immune serum globulin
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
CA1340372C
(en)
|
1984-07-09 |
1999-02-02 |
John D. Clements |
Production of e. coli lt-b enterotoxin subunit
|
NZ214503A
(en)
|
1984-12-20 |
1990-02-26 |
Merck & Co Inc |
Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
|
SE8501550L
(sv)
|
1985-03-28 |
1986-09-29 |
Almex Ab |
Sett att kontrollera en biljetts ekthet och biljett for att genomfora settet
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
US4717564A
(en)
|
1985-11-07 |
1988-01-05 |
Miles Laboratories, Inc. |
High titer varicella-zoster immune globulin for intravenous administration
|
US4665159A
(en)
|
1985-11-07 |
1987-05-12 |
Miles Laboratories, Inc. |
High titer varicella-zoster immune globulin for intravenous administration
|
US4659563A
(en)
|
1986-01-27 |
1987-04-21 |
Miles Laboratories, Inc. |
High titer anti-respiratory syncytial virus intravenous immune globulin
|
US4717766A
(en)
|
1986-01-27 |
1988-01-05 |
Miles Laboratories, Inc. |
Method of preparing high titer anti-respiratory syncytial virus intravenous immune globulin
|
US4863730A
(en)
|
1986-03-21 |
1989-09-05 |
Cenfold Holdings, S.A. |
Immunotherapy for AIDS patients
|
FR2605657A1
(fr)
|
1986-10-22 |
1988-04-29 |
Soletanche |
Procede pour la realisation d'un pieu dans le sol, machine de forage et dispositif pour la mise en oeuvre de ce procede
|
EP0399001B1
(en)
|
1988-02-01 |
1994-07-27 |
Praxis Biologics, Inc. |
T-cell epitope as carriers molecule for conjugate vaccines
|
ATE205534T1
(de)
|
1988-12-16 |
2001-09-15 |
Nederlanden Staat |
Pneumolysin-mutanten und pneumokokken-impfstoffe daraus
|
ES2055785T3
(es)
|
1989-01-17 |
1994-09-01 |
Eniricerche Spa |
Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas.
|
DE3904415C1
(es)
|
1989-02-14 |
1990-04-26 |
Intracon Handelsgesellschaft Fuer Industriebedarf M.B.H., 6200 Wiesbaden, De |
|
WO1991001146A1
(en)
|
1989-07-14 |
1991-02-07 |
Praxis Biologics, Inc. |
Cytokine and hormone carriers for conjugate vaccines
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
CA2077352A1
(en)
|
1990-03-02 |
1991-09-03 |
Uwe B. Sleytr |
Immunogenic compositions
|
IL98715A0
(en)
|
1990-08-13 |
1992-07-15 |
American Cyanamid Co |
Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
CA2059692C
(en)
|
1991-01-28 |
2004-11-16 |
Peter J. Kniskern |
Pneumoccoccal polysaccharide conjugate vaccine
|
US5679768A
(en)
|
1991-02-15 |
1997-10-21 |
Uab Research Foundation |
Epitopic regions of pneumococcal surface protein A
|
US5965141A
(en)
|
1991-02-15 |
1999-10-12 |
Uab Research Foundation |
Epitopic regions of pneumococcal surface protein a
|
DK0571538T5
(da)
|
1991-02-15 |
2002-03-04 |
Uab Research Foundation |
Strukturgen for pneumokokprotein
|
US5476929A
(en)
|
1991-02-15 |
1995-12-19 |
Uab Research Foundation |
Structural gene of pneumococcal protein
|
DE69223955T2
(de)
|
1991-04-22 |
1998-08-13 |
Massachusetts Health Research Institute, Inc. (Mhri), Boston, Mass. |
Verfahren für das screening von plasma-proben für einen effektiven antikörpernachweis gegen respiratorische viren
|
US5854416A
(en)
|
1991-11-14 |
1998-12-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
|
WO1993015758A1
(en)
|
1992-02-06 |
1993-08-19 |
Abbott Laboratories |
Composition and method of immunization with improved carrier and hapten-carrier vaccines
|
AU685047B2
(en)
|
1992-02-11 |
1998-01-15 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Dual carrier immunogenic construct
|
US5445817A
(en)
|
1992-08-21 |
1995-08-29 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
|
WO1994009818A1
(en)
|
1992-10-30 |
1994-05-11 |
The Regents Of The University Of California |
Method for stimulating production of variable region gene family restricted antibodies through b-cell superantigen vaccination
|
EP0680337A4
(en)
|
1993-01-12 |
1997-07-30 |
Anthony George Gristina |
METHODS AND COMPOSITIONS FOR DIRECT APPLICATION WITH HIGH CONCENTRATION OF ANTIBODIES, PRODUCING PASSIVE IMMUNITY.
|
US5681565A
(en)
|
1993-01-12 |
1997-10-28 |
Medical Sciences Research Institute |
Methods and compositions for passive immunotherapy
|
ES2231770T3
(es)
|
1993-03-05 |
2005-05-16 |
Wyeth Holdings Corporation |
Nuevos plasmidos para la produccion de proteina crm y toxina difterica.
|
CA2116261A1
(en)
|
1993-04-20 |
1994-10-21 |
David E. Briles |
Epitopic regions of pneumococcal surface protein a
|
US5455032A
(en)
|
1993-07-29 |
1995-10-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Use of phosphocholine hapten conjugates in vaccines
|
DE122009000058I1
(de)
|
1993-09-22 |
2009-12-31 |
Jackson H M Found Military Med |
Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
|
CA2176114A1
(en)
|
1993-11-10 |
1995-05-18 |
Clifford M. Snapper |
Cytokines from natural killer or t cells
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
US5681570A
(en)
|
1995-01-12 |
1997-10-28 |
Connaught Laboratories Limited |
Immunogenic conjugate molecules
|
KR19990007777A
(ko)
|
1995-06-07 |
1999-01-25 |
듀크두플레시스 |
면역성 및 면역자극성 올리고당 조성물 및 이를 제조하고 이용하는 방법
|
WO1996040242A1
(en)
|
1995-06-07 |
1996-12-19 |
Smithkline Beecham Biologicals S.A. |
Vaccine comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
|
JP2000502995A
(ja)
|
1995-12-06 |
2000-03-14 |
ヘンリー エム.ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディスン |
Bリンパ球による抗体放出を刺激する組成物および方法
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
ITPN960013A1
(it)
|
1996-02-26 |
1997-08-26 |
Marcello Piazza |
Farmaco atto a proteggere l'individuo dal contagio di epatite virale, ecc.
|
SE9601158D0
(sv)
|
1996-03-26 |
1996-03-26 |
Stefan Svenson |
Method of producing immunogenic products and vaccines
|
EP0941335A2
(en)
|
1996-10-31 |
1999-09-15 |
Human Genome Sciences |
Streptococcus pneumoniae polynucleotides and sequences
|
CN1241937A
(zh)
|
1996-11-22 |
2000-01-19 |
普罗克特和甘保尔公司 |
化妆品组合物
|
PT848011E
(pt)
|
1996-12-16 |
2001-08-30 |
Staat Nl Verteg Door Min Welzi |
Metodo para acoplar polisacaridos a proteinas
|
US6248334B1
(en)
|
1997-01-08 |
2001-06-19 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process
|
KR19980067137A
(ko)
|
1997-01-31 |
1998-10-15 |
박원훈 |
알긴산염 초미세과립구를 이용한 폐렴구균 감연중에 대한 백신
|
DE19708537A1
(de)
|
1997-03-03 |
1998-09-10 |
Biotechnolog Forschung Gmbh |
Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc.
|
US6299881B1
(en)
|
1997-03-24 |
2001-10-09 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
|
ATE328611T1
(de)
|
1997-03-27 |
2006-06-15 |
Pasteur Institut |
Multiple,kohlenhydrathaltige glycopeptid-antigene,daraus entwickelte impfstoffe sowie deren verwendung
|
DE69826851T2
(de)
|
1997-04-24 |
2005-02-10 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Kopplung unmodifizierter proteinen an haloacyl- oder dihaloacyl-derivatisierten polysacchariden zur herstellung von protein-polysaccharide impfstoffen
|
FR2763244B1
(fr)
|
1997-05-14 |
2003-08-01 |
Pasteur Merieux Serums Vacc |
Composition vaccinale multivalente a porteur mixte
|
HUP0002475A3
(en)
|
1997-07-21 |
2002-01-28 |
Baxter Healthcare S A Wallisel |
Modified immunogenic pneumolysin compositions as vaccines
|
US6224880B1
(en)
|
1997-09-24 |
2001-05-01 |
Merck & Co., Inc. |
Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines
|
US5965714A
(en)
|
1997-10-02 |
1999-10-12 |
Connaught Laboratories, Inc. |
Method for the covalent attachment of polysaccharides to protein molecules
|
BR9907884A
(pt)
|
1998-02-12 |
2000-10-24 |
American Cyanamid Co |
Composição de vacina, processos para gerar uma resposta imune em um antìgeno pneumocócico, para aumentar resposta de ifn-gama em uma vacina pneumocócica, e para gerar anticorpos de fixação complementar para uma resposta protetora a um patógeno, composição imunogênica, e, processo para gerar uma resposta imune em um antìgeno meningocócico
|
US5985264A
(en)
|
1998-03-05 |
1999-11-16 |
The Medical College Of Ohio |
IL-12 Stimulation of Neonatal immunity
|
US6645503B1
(en)
|
1998-03-10 |
2003-11-11 |
Wyeth Holdings Corporation |
Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria
|
WO1999047168A2
(en)
|
1998-03-16 |
1999-09-23 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties
|
GB9808932D0
(en)
|
1998-04-27 |
1998-06-24 |
Chiron Spa |
Polyepitope carrier protein
|
AU5565599A
(en)
|
1998-08-14 |
2000-03-06 |
Dante J. Marciani |
Chemically modified saponins and the use thereof as adjuvants
|
DE69941574D1
(de)
|
1998-08-19 |
2009-12-03 |
Baxter Healthcare Sa |
Immunogenes beta-propionamido-gebundenes polysaccharid-protein konjugat geeignet als impfstoff und hergestellt bei verwendung von n-acryloyliertem polysaccharid
|
US6692739B1
(en)
|
1998-08-31 |
2004-02-17 |
Inhibitex, Inc. |
Staphylococcal immunotherapeutics via donor selection and donor stimulation
|
EP1121149A4
(en)
|
1998-08-31 |
2002-03-20 |
Inhibitex Inc |
IMMUNOTHERAPY METHOD FOR STAPHYLOCOCCAL INFECTIONS INCLUDING DONOR SELECTION AND DONOR STIMULATION
|
US6585973B1
(en)
|
1998-10-29 |
2003-07-01 |
Henry M. Jackson Foundation For The Advancement Of Military Medicine |
Method for preparing solid phase conjugated vaccine
|
ES2558160T3
(es)
|
1998-12-09 |
2016-02-02 |
Phyton Holdings, Llc |
Glicoproteínas que tienen glicosilación de tipo humano
|
GB9902659D0
(en)
|
1999-02-05 |
1999-03-31 |
Microbiological Res Authority |
Assay with reduced background
|
EP1034792A1
(en)
|
1999-03-11 |
2000-09-13 |
Pasteur Merieux Serums Et Vaccins |
Intranasal delivery of pneumococcal polysaccharide vaccines
|
EP1035137A1
(en)
|
1999-03-12 |
2000-09-13 |
Pasteur Merieux Serums Et Vaccins |
Method for the reductive amination of polysaccharides
|
GB9909077D0
(en)
|
1999-04-20 |
1999-06-16 |
Smithkline Beecham Biolog |
Novel compositions
|
HU228499B1
(en)
|
1999-03-19 |
2013-03-28 |
Smithkline Beecham Biolog |
Streptococcus vaccine
|
GB9906437D0
(en)
|
1999-03-19 |
1999-05-12 |
Smithkline Beecham Biolog |
Vaccine
|
JP2002541808A
(ja)
|
1999-04-09 |
2002-12-10 |
テクラブ, インコーポレイテッド |
ポリサッカリド結合体ワクチンのための組換えトキシンaタンパク質キャリア
|
CO5241277A1
(es)
|
1999-04-20 |
2003-01-31 |
Glaxosmithkline Biolog Sa |
Vacuna
|
WO2000062802A2
(en)
|
1999-04-20 |
2000-10-26 |
Smithkline Beecham Biologicals Sa |
Vaccine comprising rsv antigen and cpg oligonucleotide
|
WO2000063385A2
(en)
|
1999-04-21 |
2000-10-26 |
Powderject Vaccines, Inc. |
Nucleic acid immunization
|
US6706267B1
(en)
|
1999-09-14 |
2004-03-16 |
Arkion Life Sciences Llc |
Glucosamine and egg for reducing inflammation
|
US6382204B1
(en)
|
1999-10-14 |
2002-05-07 |
Becton Dickinson And Company |
Drug delivery system including holder and drug container
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US6537552B1
(en)
|
1999-10-19 |
2003-03-25 |
Iowa State University Research Foundation |
Vaccine adjuvant
|
DE10012370A1
(de)
|
2000-03-14 |
2001-09-27 |
Chiron Behring Gmbh & Co |
Adjuvans für Vakzinen
|
FR2806304B1
(fr)
|
2000-03-17 |
2002-05-10 |
Aventis Pasteur |
Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
WO2001096368A2
(en)
|
2000-06-14 |
2001-12-20 |
Cytovax Biotechnologies, Inc. |
Use of coiled-coil structural scaffold to generate structure-specific peptides
|
UA85853C2
(uk)
|
2000-06-29 |
2009-03-10 |
Глаксосмітклайн Байолоджікалз С.А. |
Полівалентна імуногенна композиція
|
AUPQ846900A0
(en)
|
2000-06-29 |
2000-07-27 |
Aruba International Pty Ltd |
A vaccine
|
US6673905B2
(en)
|
2000-08-09 |
2004-01-06 |
The United States Of America As Represented By The Department Of Health And Human Services |
Conjugation of biomolecules using Diels-Alder cycloaddition
|
US6962700B1
(en)
|
2000-09-13 |
2005-11-08 |
Atopix Pharmaceuticals Corporation |
Method of manufacturing immune globulin
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
FR2816844A1
(fr)
|
2000-11-17 |
2002-05-24 |
Pf Medicament |
Domaine periplasmique d'une proteine omp d'enterobacterie et son utilisation comme porteur et/ou adjuvant
|
FR2819724B1
(fr)
|
2001-01-22 |
2005-05-13 |
Inst Necker |
Moyens pour induire une reponse immune aux antigenes bacteriens polysccharidiques et aux structures proteiques des capsides de virus
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
IL158297A0
(en)
|
2001-12-05 |
2004-05-12 |
Cangene Corp |
Pharmaceutical compositions containing immune globulin and methods for the preparation thereof
|
GB0130215D0
(en)
|
2001-12-18 |
2002-02-06 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US20030118591A1
(en)
|
2001-12-21 |
2003-06-26 |
Joshua Levy |
Passive hyperimmune antibody therapy in the treatment of anthrax
|
US7718375B2
(en)
|
2002-02-27 |
2010-05-18 |
Binax, Inc. |
Modification of bioassays for detection of antigens characteristic of bacteria that are causative of ear and respiratory infections to eliminate false positive results caused by nasopharyngeal colonization of children
|
US20030211110A1
(en)
|
2002-05-07 |
2003-11-13 |
Laniado Kiryat Sanz Hospital |
Pharmaceutical compositions and articles of manufacture useful in reversal of a clinical epiosode of an incurable disease and methods of use thereof
|
AU2002309259A1
(en)
|
2002-05-09 |
2003-11-11 |
Massimo Porro |
Improved polysaccharide and glycoconjugate vaccines_____________
|
ES2451620T3
(es)
|
2002-11-07 |
2014-03-28 |
Synergy America, Inc. |
Composiciones y métodos destinados a tratar o prevenir la infección neumocócica
|
WO2004052394A1
(en)
|
2002-12-06 |
2004-06-24 |
Biosynth S.R.L. |
Broad-spectrum lps based vaccines of unencapsulated strains of haemophilus influenzae and other pathogenic species of gram-negative bacteria
|
FR2850106B1
(fr)
|
2003-01-17 |
2005-02-25 |
Aventis Pasteur |
Conjugues obtenus par amination reductrice du polysaccharide capsulaire du pneumocoque de serotype 5
|
GB0301433D0
(en)
|
2003-01-22 |
2003-02-19 |
Adjuvantix Ltd |
Protein adjuvant
|
WO2004097000A2
(en)
|
2003-04-29 |
2004-11-11 |
Purdue Research Foundation |
Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions
|
GB0313916D0
(en)
|
2003-06-16 |
2003-07-23 |
Glaxosmithkline Biolog Sa |
Vaccine composition
|
BRPI0411854A
(pt)
|
2003-06-23 |
2006-08-29 |
Baxter Int |
veìculos protéicos para vacinas
|
BRPI0413309B8
(pt)
|
2003-08-06 |
2021-05-25 |
The Government Of The Us Secretary Department Of Health And Human Services |
método para a preparação de uma vacina conjugada de polissacarídeo-proteína
|
US6984492B2
(en)
|
2003-09-05 |
2006-01-10 |
Talecris Biotherapeutics, Inc. |
Methods and compositions for treating herpes infections
|
US20050070876A1
(en)
|
2003-09-26 |
2005-03-31 |
Penjet Corporation |
Method and apparatus for administering a vaccine or other pharmaceutical
|
MY144231A
(en)
|
2003-12-17 |
2011-08-15 |
Wyeth Corp |
Aß IMMUNOGENIC PEPTIDE CARRIER CONJUGATES AND METHODS OF PRODUCING SAME
|
UA93854C2
(ru)
|
2003-12-17 |
2011-03-25 |
Вайет Ллк |
Иммуногенный конъюгат и способ его получения
|
US20090104220A1
(en)
|
2003-12-18 |
2009-04-23 |
Elisabetta Bianchi |
Method to Make a Peptide-Carrier Conjugate with a High Immunogenicity
|
US20050287146A1
(en)
|
2003-12-19 |
2005-12-29 |
Joseph Patti |
Method of inhibiting Candida-related infections using donor selected or donor stimulated immunoglobulin compositions
|
WO2005065382A2
(en)
|
2003-12-31 |
2005-07-21 |
University Of Rochester |
Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof
|
NZ530709A
(en)
|
2004-01-21 |
2006-07-28 |
Agres Ltd |
Improved IGA production method
|
US20050158329A1
(en)
|
2004-01-21 |
2005-07-21 |
Ghosh Swapan K. |
Novel phytol derived immunoadjuvants and their use in vaccine formulations
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
EP1781326A4
(en)
|
2004-06-04 |
2009-01-14 |
Pharmexa Inc |
INDUCTION OF AN IMMUNE RESPONSE AGAINST STREPTOCOKE PENUMONIA POLYSACCHARIDES
|
CA2472818A1
(en)
|
2004-06-30 |
2005-12-30 |
Institut Pasteur |
Carbohydrate-phosphorylcholine conjugate molecules and their use in vaccinal, therapeutic and diagnostic applications
|
WO2006093524A2
(en)
|
2004-07-16 |
2006-09-08 |
The General Hospital Corporation |
Antigen-carbohydrate conjugates
|
US7718624B2
(en)
|
2004-09-01 |
2010-05-18 |
Sitkovsky Michail V |
Modulation of immune response and inflammation by targeting hypoxia inducible factors
|
GB0419846D0
(en)
|
2004-09-07 |
2004-10-13 |
Chiron Srl |
Vaccine adjuvants for saccharides
|
GB0421083D0
(en)
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Purification process
|
EP1652859A1
(en)
*
|
2004-11-02 |
2006-05-03 |
ZLB Behring AG |
Immunoglobulin fractions
|
KR20070086896A
(ko)
|
2004-12-02 |
2007-08-27 |
도만티스 리미티드 |
항il1r1 단일 도메인 항체 및 치료적 용도
|
BRPI0519086A2
(pt)
|
2004-12-16 |
2008-12-23 |
Stichting Top |
bactÉria gram-positiva, nço invasiva, nço patogÊnica, vetor de dna, mÉtodo para a produÇço heteràloga de polissacarÍdeos capsulares complexos (cps) em uma bactÉria gram-positiva, nço invasiva, nço patogÊnica, e, composiÇço farmaceuticamente aceitÁvel
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
ATE531389T1
(de)
|
2005-01-28 |
2011-11-15 |
Univ Northwest |
Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz
|
WO2006084467A1
(en)
|
2005-02-11 |
2006-08-17 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides
|
CN113198012A
(zh)
|
2005-04-08 |
2021-08-03 |
惠氏有限责任公司 |
多价肺炎球菌多糖-蛋白质缀合物组合物
|
US20070009542A1
(en)
|
2005-07-05 |
2007-01-11 |
Galit Levin |
Method and device for transdermal immunization
|
CN1899609A
(zh)
|
2005-07-19 |
2007-01-24 |
复旦大学附属眼耳鼻喉科医院 |
肺炎球菌多糖蛋白偶联疫苗及其制备方法
|
US8354249B2
(en)
|
2005-08-11 |
2013-01-15 |
Omrix Biopharmaceuticals Ltd. |
Intravenous immunoglobulin composition
|
EP1937304A2
(en)
|
2005-08-24 |
2008-07-02 |
Novartis Vaccines and Diagnostics S.r.l. |
Zwitterionization of capsular saccharides
|
ES2374648T3
(es)
|
2005-09-30 |
2012-02-20 |
Lipoxen Technologies Limited |
Composiciones de vacunas liposómicas que comprenden un antígeno polisacárido y un adyuvante proteico.
|
US20070231344A1
(en)
|
2005-10-28 |
2007-10-04 |
The Brigham And Women's Hospital, Inc. |
Conjugate vaccines for non-proteinaceous antigens
|
CA2628397C
(en)
|
2005-11-04 |
2013-08-20 |
Novartis Vaccines And Diagnostics S.R.L. |
Changing th1/th2 balance in split influenza vaccines with adjuvants
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
AR058707A1
(es)
|
2005-12-22 |
2008-02-20 |
Glaxosmithkline Biolog Sa |
Vacuna, procedimiento para fabricarla y su uso
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
WO2007084856A2
(en)
|
2006-01-13 |
2007-07-26 |
Baxter International Inc. |
Method for purifying polysaccharides
|
ES2409844T3
(es)
|
2006-01-30 |
2013-06-28 |
Grifols Therapeutics Inc. |
Metodo para el tratamiento y la profilaxis de enfermedades relacionadas con la deposicion de amiloide utilizando IgM
|
CN101024079B
(zh)
|
2006-02-17 |
2012-02-01 |
福州昌晖生物工程有限公司 |
肺炎链球菌多糖-外膜蛋白结合疫苗及制备方法
|
BRPI0708079A2
(pt)
|
2006-02-17 |
2011-05-17 |
Novartis Ag |
purificação de antìgenos bacterianos
|
BRPI0708849B1
(pt)
|
2006-03-17 |
2022-05-17 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Métodos para a preparação de conjugados imunogênicos multivalentes complexos, os referidos conjugados, e composições farmacêuticas
|
TR201807355T4
(tr)
|
2006-03-22 |
2018-06-21 |
Glaxosmithkline Biologicals Sa |
Meningokokkal konjugatlarla immünizasyon rejimleri.
|
GB0606856D0
(en)
|
2006-04-05 |
2006-05-17 |
Univ Leicester |
Vaccine compositions
|
US8414899B2
(en)
|
2006-04-11 |
2013-04-09 |
Yeda Research And Development Co. Ltd. |
Vaccines comprising multimeric HSP60 peptide carriers
|
ES2658851T3
(es)
|
2006-08-07 |
2018-03-12 |
President And Fellows Of Harvard College |
Vacunas de matriz de proteína y métodos de preparación y administración de tales vacunas
|
EP2081953A2
(en)
|
2006-08-17 |
2009-07-29 |
The UAB Research Foundation |
Immunogenic pcpa polypeptides and uses thereof
|
US20080066739A1
(en)
|
2006-09-20 |
2008-03-20 |
Lemahieu Edward |
Methods and systems of delivering medication via inhalation
|
US8722055B2
(en)
|
2006-09-27 |
2014-05-13 |
St. Jude Children's Research Hospital |
Synthetic Streptococcus pneumoniae vaccine
|
US7597891B2
(en)
|
2006-12-13 |
2009-10-06 |
Simon Michael R |
Synthesis of human secretory IgA for the treatment of Clostridium difficile associated diseases
|
GB0700135D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB0700136D0
(en)
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
GB0703369D0
(en)
|
2007-02-21 |
2007-03-28 |
Health Prot Agency |
Compositions Comprising Capsular Polysaccharides and Their Use as Vaccines
|
KR20150021127A
(ko)
|
2007-03-23 |
2015-02-27 |
와이어쓰 엘엘씨 |
스트렙토코커스 뉴모니아 협막 다당류를 제조하기 위한 단축 정제 방법
|
WO2008119358A2
(en)
|
2007-03-30 |
2008-10-09 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
|
MX2009012777A
(es)
|
2007-05-25 |
2009-12-16 |
Novartis Ag |
Antigenos pilus de streptococcus pneumoniae.
|
CA2692069C
(en)
|
2007-06-20 |
2016-10-18 |
Baxter Healthcare S.A. |
Modified polysaccharides for conjugate vaccines
|
EP2167121B1
(en)
|
2007-06-26 |
2015-09-02 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
GB0713880D0
(en)
|
2007-07-17 |
2007-08-29 |
Novartis Ag |
Conjugate purification
|
GB0714963D0
(en)
|
2007-08-01 |
2007-09-12 |
Novartis Ag |
Compositions comprising antigens
|
EP2198303A4
(en)
|
2007-09-10 |
2011-08-03 |
Cheryl A Nickerson |
BASED ON THE CULTURE OF MICRO-ORGANISMS UNDER LOW-DIMENT LIQUIDITY CONDITIONS AND METHODS OF COMPOSITION
|
AU2008335457B2
(en)
|
2007-12-07 |
2015-04-16 |
Glaxosmithkline Biologicals S.A. |
Compositions for inducing immune responses
|
WO2009106085A1
(en)
|
2008-02-28 |
2009-09-03 |
Nordic Vaccine A/S |
Vaccine compositions comprising saccharide antigens
|
JP2011519974A
(ja)
|
2008-05-12 |
2011-07-14 |
ストロックス バイオファーマスーティカルズ,エルエルシー |
黄色ブドウ球菌(Staphylococcusaureus)に特異的な抗体製剤
|
WO2009143413A1
(en)
|
2008-05-22 |
2009-11-26 |
Children'smedical Center Corporation |
Synergistic immunogenic fusion protein-polysaccharide conjugate
|
US20100040601A1
(en)
|
2008-06-10 |
2010-02-18 |
Cantin Edouard M |
Compositions and methods for treating herpes simplex virus infections and related diseases
|
WO2010015701A1
(en)
|
2008-08-08 |
2010-02-11 |
Intercell Ag |
Improved bacterial polysaccharide-polypeptide conjugate compositions
|
CN102239253A
(zh)
|
2008-12-03 |
2011-11-09 |
普罗蒂亚维仕尼科技有限公司 |
谷氨酰tRNA合成酶(GtS)片段
|
WO2010079464A1
(en)
|
2009-01-12 |
2010-07-15 |
Novartis Ag |
Cna_b domain antigens in vaccines against gram positive bacteria
|
US20110301335A1
(en)
|
2009-02-19 |
2011-12-08 |
Stephen Duffield |
Anti-tnfr1 polypeptides, antibody variable domains & antagonists
|
CN102421449A
(zh)
|
2009-03-24 |
2012-04-18 |
诺华有限公司 |
含14型肺炎球菌糖的组合
|
AU2010227220B2
(en)
|
2009-03-24 |
2014-11-13 |
Glaxosmithkline Biologicals S.A. |
Combinations of meningococcal factor H binding protein and pneumococcal saccharide conjugates
|
US8003112B2
(en)
|
2009-04-16 |
2011-08-23 |
Howard University |
Meningococcal and pneumococcal conjugate vaccine and method of using same
|
CA2757620C
(en)
|
2009-04-30 |
2016-04-26 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
US20120121578A1
(en)
|
2009-05-13 |
2012-05-17 |
Gliknik Inc. |
Methods of using immunoglobulin aggregates
|
US20120135037A1
(en)
|
2009-06-01 |
2012-05-31 |
Mizel Steven B |
Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
|
WO2010150242A2
(en)
|
2009-06-25 |
2010-12-29 |
Protea Vaccine Technologies Ltd. |
Immunogenic streptococcus pneumoniae peptides and peptide-multimers
|
CN102548572A
(zh)
|
2009-06-29 |
2012-07-04 |
健诺西生物科学公司 |
抗肺炎链球菌的疫苗和组合物
|
CN101590224A
(zh)
|
2009-06-30 |
2009-12-02 |
广州精达医学科技有限公司 |
高效14价肺炎球菌结合疫苗
|
MX2012002932A
(es)
|
2009-09-09 |
2012-09-07 |
Matrivax Res & Dev Corp |
Vacunas de matriz proteinica de inmunogenicidad mejorada.
|
AU2010300380B2
(en)
|
2009-10-02 |
2016-06-09 |
University Of Iowa Research Foundation |
Methods of improving vaccine immunogenicity
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
KR20110068831A
(ko)
|
2009-12-16 |
2011-06-22 |
재단법인 전라남도생물산업진흥재단 |
리포좀 조성물, 그 제조방법, 및 폐렴 백신으로서의 그 용도
|
JP5781542B2
(ja)
|
2009-12-30 |
2015-09-24 |
ノバルティス アーゲー |
E.coliキャリアタンパク質に結合体化した多糖免疫原
|
US20130209564A1
(en)
|
2010-02-22 |
2013-08-15 |
Shyam M. Rele |
Polysaccharide Particle Vaccines
|
CN101785857B
(zh)
|
2010-03-05 |
2012-09-26 |
成都安特金生物技术有限公司 |
一种新的肺炎球菌结合疫苗及其制备方法
|
GB201003924D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
CN102068690A
(zh)
|
2010-12-31 |
2011-05-25 |
北京民海生物科技有限公司 |
多价肺炎球菌荚膜多糖结合疫苗及其制备方法
|
US20130108619A1
(en)
|
2011-11-02 |
2013-05-02 |
Isaac Melamed |
Intravenous immunoglobulin processing, diagnostic, and treatment systems and methods
|
US9815886B2
(en)
*
|
2014-10-28 |
2017-11-14 |
Adma Biologics, Inc. |
Compositions and methods for the treatment of immunodeficiency
|